Autopsy report · NCT01095094
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
Cause of deathFutility
“Study did not meet its primary objective”
Life of this trial
- Registered 1 year 2 months after it had already started.
- Ran for about 2 years 10 months before it stopped.
- 19 participants enrolled.
- Results were posted on the registry 1 year 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Case Comprehensive Cancer Center
- Sponsor type
- University, hospital or other
- Conditions
- Brain Tumor; Anaplastic Astrocytoma; Anaplastic Ependymoma; Anaplastic Oligodendroglioma; Brain Stem Glioma; Giant Cell Glioblastoma
- Interventions
- ritonavir; lopinavir
- Participants
- 19
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
“Study design was inadequate and would not achieve study endpoints” - Whole Body Vibration for OSA
“Study was not funded, and therefore not conducted” - Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia
“This study did not accrue any subjects and due to this will be closed.” - Prevalence of Hepatitis B Infection in the Galilee Region, Israel
“The study was not carried out due to lack of funding and budget problems” - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
“Decision was made to not go forward with the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.